ATM and breast carcinoma: Two other mutations, one missense 7271T→G and one exon 11 splice-site mutation IVS10–6T→G, associated with high risk of breast cancer, identified by the Australian Breast Cancer Family Study/Cancer Family Registry for Breast Cancer Studies, were characterized in heterozygous cell lines by the expression and activity analyses of ATM.